Ceapro and McMaster extend partnership to develop Covid-19 therapy
This assessment in experimental models of lung fibrosis will aid in progressing the technology into a Phase I clinical trial.
Covid-19
Latest in
Covid-19
UK health data collaboration paves the way to study long Covid symptoms
The University of Birmingham's long Covid study is one of the success stories exploring the global potential of data-driven healthcare,…
Moderna reports total revenues of $4.7bn in Q2 2022
Four vaccines for infectious diseases are currently in the Phase III development stage.
Sinovac’s Covid-19 vaccine gets approval for use in children in Hong Kong
The vaccination schedule approved for use in children aged age six months to three years is the same as those…
EC’s HERA signs Covid-19 vaccine procurement deal with HIPRA
The HIPRA bivalent recombinant protein Covid-19 vaccine is presently under the EMA’s rolling review.
Samsung Biologics and GreenLight conclude Covid-19 vaccine engineering run
The clinical trial of GreenLight’s Covid-19 booster vaccine is anticipated to commence this year.
GreenLight and US NIH partner to develop Covid-19 vaccine for variants
The parties aim to manufacture vaccines with lasting immune responses compared to existing ones.
Moderna signs contract to supply Covid-19 booster vaccines to the US
The initial 66 million vaccine doses are anticipated to be supplied this year.